ADMA Biologics Inc (ADMA)
6.27
+0.07
(+1.13%)
USD |
NASDAQ |
Apr 19, 16:00
6.29
+0.02
(+0.32%)
After-Hours: 18:30
ADMA Biologics Price to Book Value: 10.58 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 10.47 |
| April 17, 2024 | 10.20 |
| April 16, 2024 | 10.40 |
| April 15, 2024 | 10.09 |
| April 12, 2024 | 10.16 |
| April 11, 2024 | 10.50 |
| April 10, 2024 | 10.20 |
| April 09, 2024 | 10.31 |
| April 08, 2024 | 10.50 |
| April 05, 2024 | 10.79 |
| April 04, 2024 | 10.60 |
| April 03, 2024 | 10.72 |
| April 02, 2024 | 10.87 |
| April 01, 2024 | 11.04 |
| March 28, 2024 | 11.14 |
| March 27, 2024 | 11.38 |
| March 26, 2024 | 10.97 |
| March 25, 2024 | 10.79 |
| March 22, 2024 | 10.62 |
| March 21, 2024 | 10.45 |
| March 20, 2024 | 10.67 |
| March 19, 2024 | 10.45 |
| March 18, 2024 | 10.03 |
| March 15, 2024 | 10.11 |
| March 14, 2024 | 10.16 |
| Date | Value |
|---|---|
| March 13, 2024 | 10.57 |
| March 12, 2024 | 10.50 |
| March 11, 2024 | 10.43 |
| March 08, 2024 | 10.70 |
| March 07, 2024 | 10.40 |
| March 06, 2024 | 10.33 |
| March 05, 2024 | 9.790 |
| March 04, 2024 | 9.655 |
| March 01, 2024 | 9.318 |
| February 29, 2024 | 9.047 |
| February 28, 2024 | 9.081 |
| February 27, 2024 | 9.318 |
| February 26, 2024 | 9.115 |
| February 23, 2024 | 8.879 |
| February 22, 2024 | 8.795 |
| February 21, 2024 | 8.661 |
| February 20, 2024 | 8.611 |
| February 16, 2024 | 8.828 |
| February 15, 2024 | 9.029 |
| February 14, 2024 | 8.912 |
| February 13, 2024 | 8.644 |
| February 12, 2024 | 9.129 |
| February 09, 2024 | 8.761 |
| February 08, 2024 | 8.644 |
| February 07, 2024 | 8.661 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.344
Minimum
Sep 29 2021
27.77
Maximum
May 22 2019
5.288
Average
4.54
Median
Jul 05 2019
Price to Book Value Benchmarks
| Vanda Pharmaceuticals Inc | 0.5401 |
| Puma Biotechnology Inc | 4.524 |
| ANI Pharmaceuticals Inc | 3.186 |
| Bristol-Myers Squibb Co | 3.361 |
| Ligand Pharmaceuticals Inc | 1.833 |
Price to Book Value Related Metrics
| PS Ratio | 5.438 |
| Price to Free Cash Flow | 367.71 |
| Price | 6.27 |
| Earnings Yield | -2.07% |
| Market Cap | 1.431B |
| Operating PE Ratio | 64.92 |